As the CD4(+) T cell count gradually decreased, the higher the baseline WHO clinical stage, and the longer the time from diagnosis to start of treatment, the risk of death proportion increased significantly, showing a notable trend relationship ( Table 1 ).
← all excerpts
Survival Analysis of Antiretroviral Treatment for PLWH in Sichuan Province, China, 2003-2022: A Large Retrospective Cohort Study.
2
—
—
The sentences
The risk of death was 1.27 times higher for those whose time from diagnosis to initiation of treatment exceeds 12 months compared to those within 3 months, with an increasing trend in mortality rates among PLWH as the duration from diagnosis to treatment initiation increases.